Literature DB >> 10512864

Apoptosis induced by the nuclear death domain protein p84N5 is inhibited by association with Rb protein.

J Doostzadeh-Cizeron1, R Evans, S Yin, D W Goodrich.   

Abstract

Rb protein inhibits both cell cycle progression and apoptosis. Interaction of specific cellular proteins, including E2F1, with Rb C-terminal domains mediates cell cycle regulation. In contrast, the nuclear N5 protein associates with an Rb N-terminal domain with unknown function. The N5 protein contains a region of sequence similarity to the death domain of proteins involved in apoptotic signaling. We demonstrate here that forced N5 expression potently induces apoptosis in several tumor cell lines. Mutation of conserved residues within the death domain homology compromise N5-induced apoptosis, suggesting that it is required for normal function. Endogenous N5 protein is specifically altered in apoptotic cells treated with ionizing radiation. Furthermore, dominant interfering death domain mutants compromise cellular responses to ionizing radiation. Finally, physical association with Rb protein inhibits N5-induced apoptosis. We propose that N5 protein plays a role in the regulation of apoptosis and that Rb directly coordinates cell proliferation and apoptosis by binding specific proteins involved in each process through distinct protein binding domains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512864      PMCID: PMC25587          DOI: 10.1091/mbc.10.10.3251

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  47 in total

1.  Retinoblastoma protein switches the E2F site from positive to negative element.

Authors:  S J Weintraub; C A Prater; D C Dean
Journal:  Nature       Date:  1992-07-16       Impact factor: 49.962

2.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

3.  Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.

Authors:  W G Kaelin; W Krek; W R Sellers; J A DeCaprio; F Ajchenbaum; C S Fuchs; T Chittenden; Y Li; P J Farnham; M A Blanar
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

4.  The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle.

Authors:  D W Goodrich; N P Wang; Y W Qian; E Y Lee; W H Lee
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

5.  E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.

Authors:  E K Flemington; S H Speck; W G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

6.  Molecular etiology of low-penetrance retinoblastoma in two pedigrees.

Authors:  T P Dryja; J Rapaport; T L McGee; T M Nork; T L Schwartz
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

7.  E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.

Authors:  J K Hsieh; S Fredersdorf; T Kouzarides; K Martin; X Lu
Journal:  Genes Dev       Date:  1997-07-15       Impact factor: 11.361

8.  The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F.

Authors:  S Bagchi; R Weinmann; P Raychaudhuri
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

Review 9.  Molecular characterization of the retinoblastoma susceptibility gene.

Authors:  D W Goodrich; W H Lee
Journal:  Biochim Biophys Acta       Date:  1993-05-25

10.  Inactivation of p53 gene in human and murine osteosarcoma cells.

Authors:  N Chandar; B Billig; J McMaster; J Novak
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

View more
  11 in total

1.  Tracking Effects of SIL1 Increase: Taking a Closer Look Beyond the Consequences of Elevated Expression Level.

Authors:  Thomas Labisch; Stephan Buchkremer; Vietxuan Phan; Laxmikanth Kollipara; Christian Gatz; Chris Lentz; Kay Nolte; Jörg Vervoorts; José Andrés González Coraspe; Albert Sickmann; Stephanie Carr; René P Zahedi; Joachim Weis; Andreas Roos
Journal:  Mol Neurobiol       Date:  2017-04-11       Impact factor: 5.590

2.  The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes.

Authors:  Hai Xiao; David W Goodrich
Journal:  Oncogene       Date:  2005-12-08       Impact factor: 9.867

3.  Retinoblastoma protein induction by HIV viremia or CCR5 in monocytes exposed to HIV-1 mediates protection from activation-induced apoptosis: ex vivo and in vitro study.

Authors:  Bethsebah Gekonge; Andrea D Raymond; Xiangfan Yin; Jay Kostman; Karam Mounzer; Ronald G Collman; Louise Showe; Luis J Montaner
Journal:  J Leukoc Biol       Date:  2012-06-13       Impact factor: 4.962

4.  A novel form of pRb expressed during normal myelopoiesis and in tumour-associated macrophages.

Authors:  H P Liu; A M Thompson; K F Macleod
Journal:  Cell Prolif       Date:  2005-02       Impact factor: 6.831

Review 5.  Retinoblastoma-related proteins in plants: homologues or orthologues of their metazoan counterparts?

Authors:  T Durfee; H S Feiler; W Gruissem
Journal:  Plant Mol Biol       Date:  2000-08       Impact factor: 4.076

6.  Human hHpr1/p84/Thoc1 regulates transcriptional elongation and physically links RNA polymerase II and RNA processing factors.

Authors:  Yanping Li; Xiaoling Wang; Xiaojing Zhang; David W Goodrich
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

7.  K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis.

Authors:  Suizhao Wang; Shu Wang; Hoyoung Maeng; Daniel P Young; Om Prakash; Luis E Fayad; Anas Younes; Felipe Samaniego
Journal:  Blood       Date:  2006-11-07       Impact factor: 22.113

Review 8.  The RB/E2F pathway and regulation of RNA processing.

Authors:  Joseph Ahlander; Giovanni Bosco
Journal:  Biochem Biophys Res Commun       Date:  2009-05-03       Impact factor: 3.575

9.  Relationships of hHpr1/p84/Thoc1 expression to clinicopathologic characteristics and prognosis in non-small cell lung cancer.

Authors:  Jun Yang; Yanping Li; Thaer Khoury; Sadir Alrawi; David W Goodrich; Dongfeng Tan
Journal:  Ann Clin Lab Sci       Date:  2008       Impact factor: 1.256

10.  The N-terminal domain of the Drosophila retinoblastoma protein Rbf1 interacts with ORC and associates with chromatin in an E2F independent manner.

Authors:  Joseph Ahlander; Xiao-Bo Chen; Giovanni Bosco
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.